SEC Form 4
EyePoint, Inc. (EYPT) insider trading
In the 12 months to Oct 26, 2026, 3 EYPT insiders reported open-market sales of $2.0M across 9 filings; 2 insiders bought $72.0K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $2.0M
- 9 filings · 3 insiders
- Open-market purchases
- $72.0K
- 2 filings
- Pre-arranged sales (10b5-1)
- 8 of 9
- $1.1M of $2.0M sold (54%)
Who traded EYPT, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
EYPT daily close from Oct 27, 2025 to Oct 26, 2026, between $0.37 and $18.85, last $0.37. 9 sale and 2 purchase filings by 5 insiders, marked at their filing dates. Ramiro Ribeiro, Chief Medical Officer: sold $948.8K across 6 filings, first filed Nov 12, 2025, last Jul 2, 2026. Bihua Chen, Other: sold $942.2K across 1 filing, first filed Dec 8, 2025, last Dec 8, 2025. Nancy Lurker, Director: sold $150.9K across 2 filings, first filed Dec 1, 2025, last Dec 5, 2025. Karen L. Zaderej, Director: bought $52.3K across 1 filing, first filed Aug 18, 2026, last Aug 18, 2026. Jay S. Duker, President and CEO: bought $19.7K across 1 filing, first filed Mar 16, 2026, last Mar 16, 2026.
Largest mark · tap a row for others
Bihua Chen · Other
Sale $942,240
60,000 shares at $15.70 avg
Filed Dec 8, 2025 · traded Dec 4
Close on filing date $17.82
Ramiro Ribeiro · Chief Medical Officer
Chief Medical Officer
$948.8K soldBihua Chen · Other
Other
$942.2K soldNancy Lurker · Director
Director
$150.9K soldKaren L. Zaderej · Director
Director
$52.3K boughtJay S. Duker · President and CEO
President and CEO
$19.7K boughtOpen-market trades
11 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Ramiro Ribeiro | Chief Medical Officer | $948.8K | — | 6 | 100% of sales | |
| Bihua Chen | Other | $942.2K | — | 1 | — | |
| Nancy Lurker | Director | $150.9K | — | 2 | 100% of sales | |
| Karen L. Zaderej | Director | — | $52.3K | 1 | — | |
| Jay S. Duker | President and CEO | — | $19.7K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Karen L. Zaderej Director | Purchase | 10,600 | $4.93 | $52.3K | 49,100 | |
traded | Ramiro Ribeiro Chief Medical Officer | SalePre-arranged (10b5-1) | 4,875 | $15.01 | $73.2K | 0 | |
traded | Ramiro Ribeiro Chief Medical Officer | SalePre-arranged (10b5-1) | 2,437 | $15.00 | $36.6K | 0 | |
traded | Jay S. Duker President and CEO | Purchase | 1,500 | $13.15 | $19.7K | 100,665 | |
traded | Ramiro Ribeiro Chief Medical Officer | SalePre-arranged (10b5-1) | 2,438 | $17.87 | $43.6K | 0 | |
traded | Ramiro Ribeiro Chief Medical Officer | SalePre-arranged (10b5-1) | 2,437 | $15.00 | $36.6K | 0 | |
traded | Ramiro Ribeiro Chief Medical Officer | SalePre-arranged (10b5-1) | 42,544 | $17.10 | $727.3K | 0 | |
traded | Bihua Chen Other | Sale | 60,000 | $15.70 | $942.2K | 8,265,000 | |
traded | Nancy Lurker Director | SalePre-arranged (10b5-1) | 9,300 | $15.11 | $140.5K | 206,547 | |
traded | Nancy Lurker Director | SalePre-arranged (10b5-1) | 700 | $14.95 | $10.5K | 215,847 | |
traded | Ramiro Ribeiro Chief Medical Officer | SalePre-arranged (10b5-1) | 2,722 | $11.61 | $31.6K | 0 |
GET /stocks/filings/vX/form-4?tickers=EYPT&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"EYPT"
],
"issuer_cik": "0001314102",
"owner_cik": "0001530968",
"accession_number": "0001530968-26-000004",
"form_type": "4",
"filing_date": "2026-08-18",
"period_of_report": "2026-08-18",
"issuer_name": "EyePoint, Inc.",
"issuer_trading_symbol": "EYPT",
"owner_name": "Zaderej Karen L.",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-18",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10600,
"transaction_price_per_share": 4.93,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 49100,
"transaction_value": 52258,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"EYPT"
],
"issuer_cik": "0001314102",
"owner_cik": "0002013623",
"accession_number": "0002013623-26-000012",
"form_type": "4",
"filing_date": "2026-07-02",
"period_of_report": "2026-06-30",
"issuer_name": "EyePoint, Inc.",
"issuer_trading_symbol": "EYPT",
"owner_name": "Ribeiro Ramiro",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Medical Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-06-30",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2437,
"transaction_price_per_share": 15,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 2438,
"transaction_value": 36555,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 36 records
- Option exercises17 records
- Tax withholding9 records
- Gifts6 records
- Other4 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has EyePoint, Inc.'s CEO sold stock?
No. Jay S. Duker (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is EYPT’s insider data?
These are EYPT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track EYPT insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for EYPT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.